All sites C00-96,D32-33,D42-43,D45-47,D76 696 91.8 1.6 2.6 1.2 2.8
Mouth, pharynx C00-14 12 96.8 1.6 1.6 - -
  Lip C00 2 100.0 - - - -
  Tongue C02 3 100.0 - - - -
  Mouth, other C03-06 3 100.0 - - - -
  Salivary glands C07-08 2 87.5 12.5 - - -
  Pharynx C01,C09-14 3 92.9 - 7.1 - -
Digestive organs C15-26 132 90.0 0.8 4.2 2.4 2.6
  Oesophagus C15 5 96.2 - - 3.8 -
  Stomach C16 16 98.7 - 1.3 - -
  Small intestine C17 2 100.0 - - - -
  Colon C18 45 95.5 - 1.8 0.4 2.2
  Rectum, rectosigmoid C19-20 21 98.1 - 0.9 0.9 -
  Anus C21 1 100.0 - - - -
  Liver C22 7 88.2 - 8.8 2.9 -
  Gallbladder, bile ducts C23-24 6 74.2 6.5 6.5 6.5 6.5
  Pancreas C25 28 73.2 2.2 12.3 7.2 5.1
  Other digestive organs C26 2 62.5 - - - 37.5
Respiratory organs C30-39 37 74.3 7.7 10.4 4.4 3.3
  Nose, sinuses C30-31 0 100.0 - - - -
  Larynx, epiglottis C32 - - - - - -
  Lung, trachea C33-34 36 74.9 7.8 10.1 4.5 2.8
  Mediastinum, pleura C38 0 - - 100.0 - -
Bone C40-41 1 100.0 - - - -
Melanoma of the skin C43 27 100.0 - - - -
Skin, non-melanoma C44 34 99.4 - - - 0.6
Mesothelioma C45 1 100.0 - - - -
Autonomic nervous system C47 1 100.0 - - - -
Soft tissues C48-49 4 100.0 - - - -
Breast C50 213 99.2 0.2 - 0.2 0.4
Female genital organs C51-58 81 92.6 0.7 3.2 2.0 1.5
  Cervix uteri C53 8 100.0 - - - -
  Corpus uteri C54 39 98.5 - 1.0 - 0.5
  Uterus, other C55,C58 1 50.0 - 25.0 25.0 -
  Ovary C56 24 85.8 1.7 7.5 2.5 2.5
  Other female genital C51-52,C57 10 83.7 2.0 2.0 8.2 4.1
Urinary organs C64-68 33 89.2 1.2 6.0 1.2 2.4
  Kidney C64 18 87.0 - 9.8 - 3.3
  Bladder and urinary tract2 C65-68 15 91.9 2.7 1.4 2.7 1.4
Eye C69 0 100.0 - - - -
Brain, central nervous system C70-72,D32-33,D42-43 25 90.3 - 4.0 0.8 4.8
Thyroid gland C73 13 97.0 1.5 1.5 - -
Other endocrine glands C74-75 0 100.0 - - - -
Illdefined or unknown C76,C80 19 57.7 11.3 13.4 4.1 13.4
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 62 81.2 5.5 - 0.6 12.6
  Hodgkin lymphoma C81 2 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 29 97.2 2.1 - - 0.7
  Malignant immunoproliferative diseases C88 1 75.0 - - - 25.0
  Myeloma and other plasma cell tumors C90 7 63.9 8.3 - 5.6 22.2
  Leukaemia C91-95 16 80.0 7.5 - - 12.5
  Myelodysplastic syndromes D46 3 11.8 29.4 - - 58.8
  Myeloproliferaitive neoplasms D45,D47 3 43.8 - - - 56.3
Not included above
  Carcinoma in situ of the breast D05 14 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 21 100.0 - - - -
  Borderline tumour of the ovary D39 7 100.0 - - - -
  Basal cell carcinoma of the skin 132 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.